3 Einträge gefunden

1. Longer term outcomes with single-agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13-month follow-up from the pivotal DREAMM-2 study

   1. Lonial, Sagar
   2. Lee, Hans C
   3. Badros, Ashraf
   4. Trudel, Suzanne
   5. Nooka, Ajay K
   6. Chari, Ajai
   7. Abdallah, Al-Ola

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study

   1. Lonial, Sagar
   2. Lee, Hans C
   3. Badros, Ashraf
   4. Trudel, Suzanne
   5. Nooka, Ajay K
   6. Chari, Ajai
   7. Abdallah, Al-Ola

   2020 - Forschungsinformationssystem des UKE
3. In vivo vaccination effect in multiple myeloma patients treated with the monoclonal antibody isatuximab

   1. Atanackovic, Djordje
   2. Yousef, Sara
   3. Shorter, Christa
   4. Tantravahi, Srinivas K
   5. Steinbach, Mary
   6. Iglesias, Fiorella
   7. Sborov, Douglas

   2020 - Forschungsinformationssystem des UKE